A Lactate-Depleting metal organic framework-based nanocatalyst reinforces intratumoral T cell response to boost anti-PD1 immunotherapy
-
Published:2024-04
Issue:
Volume:660
Page:869-884
-
ISSN:0021-9797
-
Container-title:Journal of Colloid and Interface Science
-
language:en
-
Short-container-title:Journal of Colloid and Interface Science
Author:
Zhou Jingrong,
Hu Yunping,
Cao Yuhua,
Ding Shuaishuai,
Zeng Lijuan,
Zhang Yu,
Cao MianfuORCID,
Duan Guangjie,
Zhang Xiao,
Bian Xiu-wu,
Tian GanORCID
Reference46 articles.
1. F. Bray, J. Ferlay, I. Soerjomataram, R.L. Siegel, L.A. Torre, A. Jemal, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, Ca-Cancer J Clin. 68 (2018) 394-424.
2. Monotherapy and Combination Therapy Using Anti-Angiogenic Nanoagents to Fight Cancer;Liang;Adv. Mater.,2021
3. Cancer immunotherapy comes of age;Mellman;Nature,2011
4. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma;Hou;J. Colloid Interf. Sci.,2022
5. The Next Decade of Immune Checkpoint Therapy;Sharma;Cancer Discov.,2021